DK3356558T3 - Sirs patogenbiomarkører og anvendelser deraf - Google Patents
Sirs patogenbiomarkører og anvendelser deraf Download PDFInfo
- Publication number
- DK3356558T3 DK3356558T3 DK16849965.5T DK16849965T DK3356558T3 DK 3356558 T3 DK3356558 T3 DK 3356558T3 DK 16849965 T DK16849965 T DK 16849965T DK 3356558 T3 DK3356558 T3 DK 3356558T3
- Authority
- DK
- Denmark
- Prior art keywords
- pathogenbiom
- sirs
- markers
- sirs pathogenbiom
- pathogenbiom markers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/26—Infectious diseases, e.g. generalised sepsis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2015903986A AU2015903986A0 (en) | 2015-09-30 | Pathogen biomarkers and uses therefor | |
| PCT/AU2016/050927 WO2017054058A1 (en) | 2015-09-30 | 2016-09-30 | Pathogen biomarkers and uses therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3356558T3 true DK3356558T3 (da) | 2022-04-25 |
Family
ID=58422555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16849965.5T DK3356558T3 (da) | 2015-09-30 | 2016-09-30 | Sirs patogenbiomarkører og anvendelser deraf |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11884978B2 (da) |
| EP (1) | EP3356558B1 (da) |
| CN (1) | CN108513586A (da) |
| AU (1) | AU2016331663B2 (da) |
| DK (1) | DK3356558T3 (da) |
| WO (1) | WO2017054058A1 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017315328A1 (en) * | 2016-08-24 | 2019-03-21 | Immunexpress Pty Ltd | Systemic inflammatory and pathogen biomarkers and uses therefor |
| DE102018125324A1 (de) * | 2018-10-12 | 2020-04-16 | Universität Rostock | Verfahren zur Vorhersage einer Antwort auf die Therapie von Krankheiten |
| CN109797217A (zh) * | 2019-03-27 | 2019-05-24 | 河北医科大学第二医院 | 帕金森生物标志物及其在制备检测产品中的应用 |
| CN112342295A (zh) * | 2019-08-06 | 2021-02-09 | 中山大学孙逸仙纪念医院 | 一种检测人结直肠癌的肿瘤标志物及其应用 |
| KR102307043B1 (ko) * | 2019-12-10 | 2021-10-01 | 아주대학교산학협력단 | Wasf2 자가항체를 이용한 간세포암종 조기진단용 조성물 |
| CN111103426B (zh) * | 2019-12-19 | 2022-10-21 | 广州市妇女儿童医疗中心 | Lap3作为儿童腺病毒肺炎诊断标志物的应用 |
| CN111443206B (zh) * | 2020-03-13 | 2022-12-27 | 佛山市妇幼保健院 | 一种与儿童尘螨相关性哮喘特异性免疫治疗相关的生物标志物及应用 |
| CN111781377B (zh) * | 2020-07-13 | 2021-12-17 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 用于鉴定哺乳动物细胞病毒感染机会的方法 |
| WO2022125702A1 (en) * | 2020-12-09 | 2022-06-16 | The Regents Of The University Of California | Analysis of host gene expression for diagnosis of severe acute respiratory syndrome coronavirus 2 infection |
| CN113035298B (zh) * | 2021-04-02 | 2023-06-20 | 南京信息工程大学 | 递归生成大阶数行限制覆盖阵列的药物临床试验设计方法 |
| GB202107883D0 (en) * | 2021-06-02 | 2021-07-14 | Orph Pharma Ip Company Ltd | Biomarkers and method for classifying subjects following viral exposure |
| CN114790232A (zh) * | 2022-02-24 | 2022-07-26 | 中国人民解放军陆军军医大学 | Cnpy3蛋白作为治疗登革热靶点的用途 |
| CN116790737A (zh) * | 2022-03-15 | 2023-09-22 | 中山大学附属口腔医院 | Pik3ip1蛋白在制备诊断或治疗自身免疫性疾病的试剂或药物中的应用 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| US4932207A (en) | 1988-12-28 | 1990-06-12 | Sundstrand Corporation | Segmented seal plate for a turbine engine |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5925525A (en) | 1989-06-07 | 1999-07-20 | Affymetrix, Inc. | Method of identifying nucleotide differences |
| US7625697B2 (en) | 1994-06-17 | 2009-12-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for constructing subarrays and subarrays made thereby |
| CA2319828A1 (en) | 1998-01-29 | 1999-08-05 | Miller, Samuel | High density arrays for proteome analysis and methods and compositions therefor |
| US6406921B1 (en) | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
| EP1354037A2 (en) | 2000-04-17 | 2003-10-22 | TransTech Pharma, Inc. | Protein expression system arrays and use in biological screening |
| GB0022978D0 (en) | 2000-09-19 | 2000-11-01 | Oxford Glycosciences Uk Ltd | Detection of peptides |
| WO2002039120A1 (en) | 2000-11-09 | 2002-05-16 | Bionova Pharmaceutials, Inc. | A method for identifying the proteome of cells using an antibody library microarray |
| WO2002059601A1 (en) | 2001-01-23 | 2002-08-01 | President And Fellows Of Harvard College | Nucleic-acid programmable protein arrays |
| US20050003360A1 (en) | 2001-11-13 | 2005-01-06 | Ruo-Pang Huang | Array systems and methods |
| ES2319634T3 (es) | 2002-03-11 | 2009-05-11 | Caprotec Bioanalytics Gmbh | Compuestos y metodos para analizar el proteoma. |
| CA2505843A1 (en) | 2002-11-12 | 2004-05-27 | Becton, Dickinson And Company | Diagnosis of sepsis or sirs using biomarker profiles |
| US20080070235A1 (en) | 2003-04-02 | 2008-03-20 | Sirs-Lab Gmbh | Method for Recognizing Acute Generalized Inflammatory Conditions (Sirs), Sepsis, Sepsis-Like Conditions and Systemic Infections |
| DE102004009952B4 (de) | 2004-03-01 | 2011-06-01 | Sirs-Lab Gmbh | Verfahren zur Erkennung von Sepsis |
| US20080020379A1 (en) * | 2004-11-05 | 2008-01-24 | Agan Brian K | Diagnosis and prognosis of infectious diseases clinical phenotypes and other physiologic states using host gene expression biomarkers in blood |
| JP5150909B2 (ja) * | 2005-07-27 | 2013-02-27 | オンコセラピー・サイエンス株式会社 | 食道癌を診断する方法 |
| JP2009506759A (ja) | 2005-09-01 | 2009-02-19 | コーベット ライフ サイエンス ピーティーワイ リミテッド | 核酸の増幅、定量化、及び同定の方法。 |
| EP2078201A2 (en) | 2006-10-05 | 2009-07-15 | Agency for Science, Technology and Research | Dengue diagnosis and treatment |
| WO2010074924A1 (en) | 2008-12-23 | 2010-07-01 | University Of Utah Research Foundation | Identification and regulation of a novel dna demethylase system |
| US20110076685A1 (en) * | 2009-09-23 | 2011-03-31 | Sirs-Lab Gmbh | Method for in vitro detection and differentiation of pathophysiological conditions |
| CN103649329A (zh) * | 2010-11-26 | 2014-03-19 | ImmuneXpress有限公司 | 诊断和/或筛选剂及其用途 |
| US20140141986A1 (en) * | 2011-02-22 | 2014-05-22 | David Spetzler | Circulating biomarkers |
| WO2012174282A2 (en) | 2011-06-16 | 2012-12-20 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Biomarker compositions and methods |
| EP3367099B1 (en) * | 2012-02-09 | 2021-05-26 | Memed Diagnostics Ltd. | Signatures and determinants for diagnosing infections and methods of use thereof |
| WO2013148316A1 (en) | 2012-03-29 | 2013-10-03 | Biogen Idec Ma Inc. | Biomarkers for use in integrin therapy applications |
| AU2014284124B2 (en) | 2013-06-20 | 2020-03-12 | Immunexpress Pty Ltd | Biomarker identification |
| US20160244834A1 (en) | 2013-06-28 | 2016-08-25 | Acumen Research Laboratories Pte. Ltd. | Sepsis biomarkers and uses thereof |
| US11047010B2 (en) | 2014-02-06 | 2021-06-29 | Immunexpress Pty Ltd | Biomarker signature method, and apparatus and kits thereof |
| WO2015117205A1 (en) * | 2014-02-06 | 2015-08-13 | Immunexpress Pty Ltd | Biomarker signature method, and apparatus and kits therefor |
| GB201402293D0 (en) | 2014-02-11 | 2014-03-26 | Secr Defence | Biomarker signatures for the prediction of onset of sepsis |
| DK3371324T3 (da) | 2015-11-06 | 2021-11-15 | Immunexpress Pty Ltd | Virusbiomarkører og anvendelser deraf |
-
2016
- 2016-09-30 US US15/765,162 patent/US11884978B2/en active Active
- 2016-09-30 EP EP16849965.5A patent/EP3356558B1/en active Active
- 2016-09-30 DK DK16849965.5T patent/DK3356558T3/da active
- 2016-09-30 CN CN201680071527.0A patent/CN108513586A/zh active Pending
- 2016-09-30 AU AU2016331663A patent/AU2016331663B2/en active Active
- 2016-09-30 WO PCT/AU2016/050927 patent/WO2017054058A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| EP3356558B1 (en) | 2022-03-30 |
| EP3356558A1 (en) | 2018-08-08 |
| AU2016331663B2 (en) | 2022-04-07 |
| US20180305760A1 (en) | 2018-10-25 |
| CN108513586A (zh) | 2018-09-07 |
| EP3356558A4 (en) | 2019-07-10 |
| AU2016331663A1 (en) | 2018-04-12 |
| US11884978B2 (en) | 2024-01-30 |
| WO2017054058A1 (en) | 2017-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3448386T3 (da) | Isoquinolin-3-ylcarboxamider og fremstilling og anvendelse deraf | |
| DK3356558T3 (da) | Sirs patogenbiomarkører og anvendelser deraf | |
| DK3411398T3 (da) | Målrettede terapeutiske midler og anvendelse heraf | |
| DK3368534T3 (da) | Valbenazin-ditosylat og polymorfer deraf | |
| DK3888658T3 (da) | Eif4-a-inhiberende forbindelser og fremgangsmåder relateret dertil | |
| DK3389658T3 (da) | Glycosidasehæmmere og anvendelser deraf | |
| DK3452463T3 (da) | Amidsubstituerede pyridinyltriazolderivater og anvendelser deraf | |
| DK3303379T3 (da) | Tigit-bindende midler og anvendelser deraf | |
| DK3268470T3 (da) | Transposasepolypeptider og anvendelser deraf | |
| DK3302431T3 (da) | Taxanpartikler og anvendelse deraf | |
| DK3212189T3 (da) | Substituerede chromaner og fremgangsmåde til anvendelse deraf | |
| DK3215147T3 (da) | Neurodæmpende norketamin-forbindelser og fremgangsmåder | |
| DK3229838T3 (da) | Anti-C10orf54-antistoffer og anvendelser deraf | |
| DK3157552T3 (da) | Syntac-polypeptider og anvendelser deraf | |
| DK3126388T3 (da) | Anti-EGFRvIII-antistoffer og anvendelser deraf | |
| DK3218358T3 (da) | Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner | |
| DK3018183T3 (da) | Halogenolefinbaseret sammensætning og anvendelse deraf | |
| DK3395801T3 (da) | Arylazolforbindelse og skadedyrsbekæmpelsesmiddel | |
| DK3256598T3 (da) | Svampestammer og anvendelsesfremgangsmåder | |
| DK3265641T3 (da) | Stigørenhed og fremgangsmåde | |
| DK3161139T3 (da) | Tlr-4-specifikke aptamerer og anvendelser heraf | |
| DK3209773T3 (da) | Prolintolerante tripeptidylpeptidaser og anvendelser deraf | |
| DK3384079T3 (da) | Fibrøs konstruktion og fremgangsmåder i forbindelse hermed | |
| DK3128005T3 (da) | Sirp-alfa-variantkonstruktioner og anvendelser deraf | |
| DK3448419T3 (da) | Interferon-beta-antistoffer og anvendelser deraf |